Tata Consultancy Services (TCS) has unveiled TCS ADD AgentHub, an agentic AI platform designed to help pharmaceutical companies deploy role-based AI agents across drug development, clinical trials, and drug safety workflows. The platform is built to handle repetitive tasks while keeping human teams responsible for governance and final decision-making.
TCS ADD AgentHub is part of TCS ADD, the company’s established portfolio for clinical research and drug development. Rather than operating as a standalone tool, AgentHub serves as an AI agent layer across the suite, enabling companies to deploy AI workers within existing clinical and safety workflows for specific roles.
The platform supports use cases including clinical data review, study design, protocol digitization, literature analysis, medical monitoring and drug safety case processing. AI agents can handle repetitive activities such as data extraction and document review, while human teams retain responsibility for decision-making, governance and regulatory compliance.
TCS calls this approach its Human + AI Operating Model, with the platform designed around auditability, oversight and controlled deployment in regulated pharmaceutical environments.
According to TCS, solutions powered by AgentHub have demonstrated up to 40 percent efficiency gains in clinical data management activities. The company also claims up to a 30 percent reduction in clinical study build effort through metadata-driven automation and up to 30 percent cost savings in end-to-end safety case processing. AI-powered safety agents can reduce quality-control effort by up to 50 percent.
The figures are based on internal TCS assessments and have not been independently validated, according to the report.
Also Read: TCS Flags Employee Data Exposure, Customer Data Saf
AgentHub runs on Google Cloud’s Gemini Enterprise infrastructure. TCS said the platform is designed to address data silos across clinical research, where information can move through disconnected trial sites, safety databases and regulatory records.
The launch also fits into TCS’s wider push into agentic AI. The company said it has built more than 3,000 industry- and context-aware agents on Gemini Enterprise and received five Google Cloud Partner of the Year Awards in 2026, including the Artificial Intelligence: Agent Development award.
The agentic AI market in pharmaceuticals is estimated at $6.16 billion in 2026, with a projected 41.52 percent compound annual growth rate through 2031. TCS is positioning AgentHub as a way for pharmaceutical companies to move from AI pilots towards scalable, auditable deployment.